Dec 13, 2016 13:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 13, 2016 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced that...
Dec 13, 2016 13:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 13, 2016 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced that...
Semtech Expands LinkCharge™ Wireless Charging Platform to High-Power Industrial Applications
Dec 13, 2016 13:00 pm UTC| Business
CAMARILLO, Calif., Dec. 13, 2016 -- Semtech Corporation (Nasdaq:SMTC), a leading supplier of analog and mixed-signal semiconductors, today announced the availability of the new LinkCharge 20 Series, including two...
ADDvantage Technologies Announces Financial Results for the Fiscal Fourth Quarter of 2016
Dec 13, 2016 13:00 pm UTC| Business
BROKEN ARROW, Okla., Dec. 13, 2016 -- ADDvantage Technologies Group, Inc. (NASDAQ:AEY), today announced its financial results for the fourth quarter and fiscal year ended September 30, 2016. “The financial results for...
361 Capital Named a Best Place to Work in Money Management by Pensions & Investments
Dec 13, 2016 13:00 pm UTC| Business
DENVER, Dec. 13, 2016 -- 361 Capital, a leading boutique asset manager offering distinctive investment strategies to institutions, investment advisors and their clients, is honored to be named among the Best Places to...
Provista Diagnostics Joins Cancer Moonshot-Inspired Collaborative to Advance Blood Tests for Cancer
Dec 13, 2016 13:00 pm UTC| Business
NEW YORK, Dec. 13, 2016 -- Provista Diagnostics has joined a new collaborative announced in response to the White House Cancer Moonshot, the Blood Profiling Atlas. The Atlas is a collaborative effort among more than 20...
Dec 13, 2016 13:00 pm UTC| Business
– Regimen of intravenous (IV) formulation of SCY-078 successfully identified and characterized to support subsequent studies – – Long-term toxicology studies completed, confirming favorable safety profile of oral...